145 results

• FDA Issues Draft Guidance On Conducting Safety Trials For New Diabetes Drugs

  March 12, 2020

  Russell Maas

  A draft guidance seeks to require broader clinical trials for diabetes drugs, in an effort to better identify potential adverse health effects before they receive FDA approval.

• Some Diabetes Drugs Side Effects May Have Toxic Effects On Mitochondria, Causing Heart Problems: Study

  September 26, 2019

  Martha Garcia

  A new study indicates diabetes drugs like Avandia may cause heart problems through mitochondrial toxicity, which could be preventable through the use of other medications.

• Actos Lawsuit Filed Over Bladder Cancer Risk Years After Takeda Settled Thousands of Claims

  June 17, 2019

  Irvin Jackson

  An Actos lawsuit, filed years after many cases were settled, blames the diabetes drug for a man's bladder cancer and eventual death.

• Actos Bladder Cancer Warnings Updated by FDA to Add New Study Data Reviewed

  December 13, 2016

  Irvin Jackson

  The FDA has updated Actos label warnings with additional study information and reinforced its belief that the diabetes drug's side effects may increase the risk of bladder cancer.

• Study Finds Little Difference Between Diabetes Drugs’ Effectiveness

  July 27, 2016

  Irvin Jackson

  The findings of a new study suggest that there is little difference between a variety of diabetes drugs currently on the market, despite a wide range of risks.

• Bladder Cancer Risk with Actos Highlighted in a New Study

  April 5, 2016

  Irvin Jackson

  A new study has found that the use of Actos increases the risk of bladder cancer by 63%, and that the risks appear to be specific to that drug.

• Actos Side Effects May Increase Risk of Bone Fractures, Weight Gain: Study

  March 1, 2016

  Irvin Jackson

  Researchers warn that while Actos may prevent diabetes in some cases, users face an increased risk of bone fractures, weight gain and edema.

• Actos Trial Resolved as Settlement Reached in Two Nevada Bladder Cancer Cases

  October 13, 2015

  Irvin Jackson

  An undisclosed settlement ends an Actos bladder cancer trial that has been ongoing since late August and follows a larger settlement agreement affecting thousands of cases.

• Actos Settlement To Go Forward After Participation Threshold Reached

  September 15, 2015

  Austin Kirk

  A $2.4 billion Actos settlement can go forward now that enough plaintiffs have agreed to participate, the manufacturer has announced.

• Actos Bladder Cancer Lawsuits Headed to Trial in Nevada After Some Reject Settlement

  August 31, 2015

  Irvin Jackson

  A new Actos trial is under way in Las Vegas, over claims that warnings were withheld about the risk of bladder cancer.